CAAP vs MDA

CAAP exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and a highly attractive balance sheet compared to its sector peers. While the stock trades above its defensive Graham Number ($18.24), it remains significantly undervalued relative to its growth-based intrinsic value of $44.84 and a low forward P/E of 10.14. Explosive earnings growth (212% YoY) and strong operating margins (23.51%) drive the bullish thesis, though short-term bearish technicals and mediocre insider sentiment suggest a period of consolidation before a potential breakout.

MDA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational efficiency. The stock is trading at a significant premium, with a current price of $29.10 far exceeding both the Graham Number ($10.37) and the growth-based Intrinsic Value ($5.64). While recent Q/Q revenue growth of 44% shows short-term momentum, the stagnant YoY revenue growth (0.20%) and thin profit margins (2.24%) fail to justify the high P/E ratio of 46.94. The combination of a bearish technical trend and poor deterministic scores suggests a high risk of price correction.